Multiple Primary Malignancies

Seminars in Oncology

Volumn 31, Issue 2, 2004, Pages 264-273

  Luciani, Andrea ^a   Balducci, Lodovico ^b  

^a SAN PAOLO HOSPITAL   (Italy)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AGE; AUTOPSY; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CARCINOGENESIS; ENDOMETRIUM CANCER; GENOTYPE; HUMAN; KIDNEY CARCINOMA; MULTIPLE CANCER; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SECOND CANCER; SMOKING;

EID: 1842782760     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2003.12.035     Document Type: Article

References (69)

1. Yancik RM, Ries LAG: Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14:17-23, 2000
2. Day JC: Population Projections in the United States by Age, Sex, Race, and Hispanic origin: 1995-2050. Washington DC, US Bureau of the Census, Current Population Reports, 1996, p 1130
3. National Center for Health Statistics: Vital statistics of the United States 1989. Mortality-part B. National Center for Health Statistics, Hyattsville, MD, 1991
4. Li FP, Fraumeni JF Jr: Soft tissue sarcomas, breast cancer, and other neoplasms: A familial syndrome? Ann Intern Med 71:747-752, 1969
5. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al: A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358-5362, 1988
6. Malkin D, Jolly KW, Barbier N, et al: Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms. N Engl J Med 326:1309-1315, 1992
7. Schottenfeld D, Berg JW: Epidemiology of multiple primary cancers, in Schottenfeld D (ed): Cancer Epidemiology and Prevention: Current Concepts. Springfield, MA, Charles C. Thomas, pp 1975, pp 416-434
8. Moertel CG: Multiple primary malignant neoplasms: Historical perspectives. Cancer 40:1786-1792, 1977
9. Furberg AH, Ambrosome CB: Molecular epidemiology, biomarkers, and cancer prevention. Trends Mol Med 7:517-521, 2001
10. Jones PA: DNA methylation and cancer. Oncogene 12:5358-5360, 2002
11. Schwetz B, Gaylor D: New directions for predicting carcinogenesis. Mol Carcinog 20:275-279, 1997
12. Jacks T: lessons from the P53 mutant mouse. J Cancer Res Clin Oncol 122:319-327, 1996
13. Lynch HT, Harris RE, Lynch PM, et al: Role of heredity in multiple primary cancers. Cancer 40:1849-1854, 1977
14. Begg CB, Zhanfg Z-F, Sun M, et al: Methodology for evaluating the incidence of second primary cancers with application of smoking-related cancers from the Surveillance, Epidemiology and End-Results (SEER) program. Am J Epidemiol 142:653-664, 1995
15. Winn DM, Blot WJ: Second cancers following cancers of the buccal cavity and pharynx in Connecticut. NCI Monogr 68:25-48, 1985
16. Day GL, Blot WJ: Second primary tumors in patients with oral cancer. Cancer 70:14-19, 1992
17. Auerbach O, Gene J, Pawloski JM, et al: Carcinoma-in situ and invasive carcinoma occurring in the tracheo-bronchial trees in cases of bronchial carcinoma. J Thorac Surg 34:398-303, 1957
18. Horn PL, Thompson D: Risk of controlateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 128:309-323, 1988
19. Bernstein JL, Thompson WD, Risch N, et al: Risk factor predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer. Am J Epidemiol 136:925-936, 1992
20. Harvey EB, Brinton LA: Second cancer following cancer of the breast in Connecticut, 1935-1982. NCI Monogr 68:99-112, 1985
21. Migliore L, Coppede F: Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat Res 512:135-153, 2002
22. Anisimov V: Age as a risk factor in multistage carcinogenesis, in Balducci L, Lyman GH, Ershler WB (eds): Comprehensive Geriatric Oncology. London, UK, Harwood Academic Publisher, 1998, pp 157-178
23. Fernandez Pol JA, Douglas MG: Molecular interactions of cancer and age. Hematol Oncol Clin North Am 14:25-44, 2000
24. Ono T, Uehara Y, Saito Y, et al: Mutation theory of aging, assessed in transgenic and knock-out mice. Mech Ageing Dev 123:1543-1552, 2002
25. Repetto L, Balducci L: A case for geriatric oncology. Lancet Oncol 3:289-297, 2002
26. Campisi J: From cells to organisms: Can we learn about aging from cells "in culture". Exp Gerontol 36:607-618, 2001
27. Franceschi C, Bonafe M, Valnesiu S, et al: Inflammaging: An evolutionary perspective on immunosenescence. Ann NY Acad Sci 908:244-254, 2000
28. Goodwin J, Burns E: Immunological changes of aging, in Balducci L, Lyman GH, Ershler WB (eds): Comprehensive Geriatric Oncology. London, UK, Harwood Academic Publisher, 1998, pp 213-222
29. Ershler WB: The influence of an aging immune system on cancer incidence and progression. J Gerontol 48:b3-b7, 1993
30. Billroth CAT: Die allegemeine chirurgische pathologie und therapie. Berlin, Germany, Reimer, 1889
31. Warren S, Gates O: Multiple primary malignant tumors: a survey of the literature and statistical study. Am J Cancer 16:1358-1414, 1932
32. Roskans T: The role of immunohistochemistry in diagnosis. Clin Liver Dis 6:571-589, 2002
33. Lubin JH: Extension of analytic methods for nested and population-based incident case-control studies. J Chronic Dis 39:379-388, 1986
34. Koering SM: A cancer program's seal of approval. J Am Health Info Manage 73:40-44, 2002
35. Rabbani S, Russo P: Lack of association between renal cell carcinoma and non-Hodgkin's lymphoma. Urology 54:28-33, 1999
36. Boice TH, Day NE, Andersen A, et al: Second cancers following radiation treatment for cervical cancer: International Collaboration Among Cancer Registries. J Natl Cancer Inst Monogr 74:955-975, 1985
37. Schoenberg BS, Myers MH: Statistical methods for studying multiple primary malignant neoplasms. Cancer 40:1892-1898, 1977
38. Anderson CM, Pusztai L, Palmer JL, et al: Coincident renal cell carcinoma and non-Hodgkin's lymphoma: M.D. Anderson experience and review of the literature. J Urol 159:714-717, 1998
39. Rabbani F, Grimaldi G, Russo P: Multiple primary malignancies in renal cell carcinoma. J Urol 160:1255-1259, 1998
40. Tihan T, Filippa D: Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence. Cancer 77:2325-2329, 1996
41. Warren S, Ehrenreich T: Multiple primary malignant tumors and susceptibility to cancer. Cancer Res 4:554-570, 1944
42. Hajdu SI, Hajdu EO: Multiple primary malignant tumors. J Am Geriatr Soc 16:16-26, 1968
43. Berg JW, Foote FW: The prevalence of latent cancers in cancer patients. Arch Pathol 91:183-186, 1971
44. Stanta G, Campagner L, Cavallieri F, et al: Cancer of the oldest old: What we have learned from autopsy studies. Clin Geriatr Med 13:55-68, 1997
45. Campbell LV, Watne AL: Multiple primary malignant neoplasms. Arch Surg 99:401-405, 1969
46. Curtis RE, Boice JD, Keinerman RA, et al: Summary: Multiple primary cancers in Connecticut, 1935-1982. Natl Cancer Inst Monogr 68:219-242, 1985
47. Bordin GM, Key CR, McQuade CE, et al: Multiple primary cancers: Relative risk in New Mexico's Triethnic population. Cancer 40:793-1800, 1977
48. Teppo L, Pukkala E, Saxèn E: Multiple Cancer - An epidemiologic exercise in Finland. J Natl Cancer Inst 75:207-217, 1985
49. Storm HH, Lynge E, Østerlind A, et al: Multiple primary cancers in Denmark, 1943-1980: Influence of possible unreporting and suggested risk factors. Yale J Biol Med 59:547-559, 1996
50. Crocetti E, Buiatti E, Falini P, the Italian Multiple Primari Cancer Working Group: Multiple primary cancer incidence in Italy. Eur J Cancer 37:2449-2456, 2001
51. Mydlo JH, Gerstein M: Patients with urologic cancer and other nonurologic malignancies: Analysis of a sample and review of the literature. Urology 58:864-869, 2001
52. Wegner HEH: Multiple primary cancers in urologic patients. Urology 39:231-236, 1992
53. Salminen E, Pukkala E, Teppo L, et al: Subsequent primary cancer following bladder cancer. Eur J Cancer 30A: 303-307, 1994
54. Rabbani F, Grimaldi G, Russo P: Multiple primary malignancies in renal cell carcinoma. J Urol 160:1255-1259, 1998
55. Levi F, Randimbison L, Van-Cong T, et al: Second primary cancers in patients with lung carcinoma. Cancer 86:186-190, 1999
56. Neugut Al, Hasan H, Robinson E, et al: Bladder carcinoma and other second malignancies after radiotherapy for prostate cancer. Cancer 79:1600-1604, 1997
57. Adami H-O, Bergkvist L, Krusemo UB, et al: Breast cancer as a risk factor of other primary malignant diseases. A nationwide cohort study. J Natl Cancer Inst 73:1049-1055, 1984
58. Begg CB, Zhang Z-F, Sun M, et al: Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancer from the Surveillance, Epidemiology and End Results program. Am J Epidemiol 142:653-665, 1995
59. Halpern MT, Gillespie BW, Warner KE: Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst 17:457-464, 1993
60. Levi F, Randimbison L, Te V-C, et al: Second primary tumors after prostate carcinoma. Cancer 86:1567-1570, 1999
61. Osterlind A, Roth M, Prener A: Second cancer following cancer of the male genital tract. J Natl Cancer Inst Monogr 68:341-347, 1985
62. Klinerman RA, Liebermann JV, Li FP: Second cancer following cancer of the male genital system in Connecticut 1935-1982. J Natl Cancer Inst Monogr 68:139-147, 1985
63. Pawlish KS, Schottenfeld D, Stevenson R, et al: Risk of multiple primary cancer in prostate cancer patients in the Detroit Metropolitan area: A retrospective cohort study. Prostate 33:75-86, 1997
64. Begg C, Kantor AF, McLaughlin JK, et al: Risk of second malignancy after cancer of the renal parenchyma, renal pelvis and ureter. Cancer 58:1158-1161, 1986
65. Jensen OM, Knudsen JB, Sorensen BL: Second cancers following cancer of the urinary system in Denmark, 1943-1980. J Natl Cancer Inst Monogr 68:349-360, 1982
66. Rabbani F, Reuter VE, Katz J, et al: Second primary malignancies associated with renal cell carcinoma: Influence of histologic type. Urology 56:399-403, 2000
67. Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92:550-556, 2000
68. Cohen HJ, Pieper CF, Harris T: Markers of inflammation and coagulation predict decline in function and mortality in community-dwelling elderly. J Am Geriatr Soc 49:A3, 2001 (abstr)
69. Extermann M: Measurement and impact of comorbidity in older cancer patients. Crit Rev Hematol Oncol 35:81-200, 2000